Emami Limited (NSE:EMAMILTD)
India · Delayed Price · Currency is INR | Market Cap | 170.48B -32.7% |
| Revenue (ttm) | 39.15B +2.8% |
| Net Income | 7.48B -8.5% |
| EPS | 17.15 -8.5% |
| Shares Out | n/a |
| PE Ratio | 22.78 |
| Forward PE | 21.31 |
| Dividend | 10.00 (2.55%) |
| Ex-Dividend Date | Feb 10, 2026 |
| Volume | 4,466,772 |
| Open | 392.05 |
| Previous Close | 390.00 |
| Day's Range | 389.10 - 407.65 |
| 52-Week Range | 361.15 - 585.90 |
| Beta | 0.14 |
| Analysts | Strong Buy |
| Price Target | 518.95 (+32.39%) |
| Earnings Date | Nov 13, 2026 |
About Emami
Emami Limited, together with its subsidiaries, manufactures and markets personal and healthcare products in India and internationally. The company offers antiseptic creams, body lotions, soaps, aloe vera gels, petroleum jellies, prickly heat powders, and all-season creams under the BoroPlus brand; cool oils and talcs under the Navratna brand; ayurvedic products for pain management, immunity, digestive health, and bone and joint health, as well as pain balms, healthcare, generics, and ethical products under the Zandu brand; ayurvedic medicinal o... [Read more]
Financial Performance
In fiscal year 2026, Emami's revenue was 37.80 billion, a decrease of -0.78% compared to the previous year's 38.09 billion. Earnings were 7.75 billion, a decrease of -3.87%.
Financial StatementsAnalyst Summary
According to 23 analysts, the average rating for EMAMILTD stock is "Strong Buy." The 12-month stock price target is ₹518.95, which is an increase of 32.39% from the latest price.
News
Emami to buy back 59 lakh shares
Emami Ltd approves buyback of up to 59 lakh shares at Rs 475 each, totaling Rs 282 crore; at least Rs 211 crore to be used, raising promoter stake to 55.6%.
Emami Transcript: Q1 26/27
Revenue grew 15% year-over-year, driven by strong domestic and strategic investment portfolio growth. Margin pressures from input costs and business mix are expected to ease, with profitability set to improve. International business is anticipated to recover in the second half.
Emami Quarterly report: Q1 2027
Emami has published its Q1 2027 quarterly earnings report on August 4, 2026.
Emami Slides: Q1 2027
Emami has posted slides in relation to its Q1 2027 quarterly earnings report, which was published on August 4, 2026.
Emami Transcript: Q4 25/26
Q4 FY2026 saw revenue decline 4% year-over-year due to weak summer sales, but core domestic business excluding summer grew 11%. Gross margins expanded, and strategic investments and new channels delivered strong growth. Entering FY2027, management expects sustained growth and improved profitability.
Emami Quarterly report: Q4 2026
Emami has published its Q4 2026 quarterly earnings report on May 21, 2026.
Emami Slides: Q4 2026
Emami has posted slides in relation to its Q4 2026 quarterly earnings report, which was published on May 21, 2026.
Emami Annual report: Q4 2026
Emami has published its Q4 2026 annual report on May 21, 2026.
Emami missed its 10% revenue growth target by the widest margin in years — what went wrong in FY26
Emami Limited entered FY26 guiding for 10% revenue growth. It ended the year with revenue declining approximately 1% — a gap of 1,100 basis points between what management promised investors…
Emami misses double-digit growth target badly — revenue flat, EBITDA margins shrink in Q4 FY26
Emami Limited delivered one of its most disappointing annual performances in recent memory — failing to achieve double-digit revenue growth for FY26 despite guiding for 10% at the start of…
Emami to acquire 60% stake in IncNut Digital for Rs 321 crore
Emami Limited has announced the acquisition of a majority stake in IncNut Digital Private Limited, the parent company of personalised beauty and skincare brands Vedix and SkinKraft, in a move…
Emami acquires 73.5% stake in Axiom Ayurveda for Rs 200 crore
Emami Limited has announced its decision to acquire a 73.5% stake in Axiom Ayurveda Private Limited, an associate company, for a total consideration of up to ₹200 crore. This acquisition…
Emami Transcript: Q3 25/26
Q3 FY26 saw 11% sales growth and 15% PAT growth, with strong performance across major brands and digital channels. Gross margin and EBITDA margin improved, and rural demand showed double-digit growth. GST cuts and supply chain initiatives are expected to drive further gains.
Emami Quarterly report: Q3 2026
Emami has published its Q3 2026 quarterly earnings report on February 4, 2026.
Emami Slides: Q3 2026
Emami has posted slides in relation to its Q3 2026 quarterly earnings report, which was published on February 4, 2026.
Emami Transcript: Q2 25/26
Q2 FY26 saw a 10% revenue decline due to GST-driven trade disruptions and weak summer sales, but non-GST portfolios and international business grew. Management expects a strong H2 rebound, with winter loading recovered and GST benefits supporting future growth.
Emami Quarterly report: Q2 2026
Emami has published its Q2 2026 quarterly earnings report on November 10, 2025.
Emami Slides: Q2 2026
Emami has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on November 10, 2025.
Emami Q2 FY26 results: Profit falls 30% YoY to ₹148 crore, revenue down 10%
Emami Limited announced its consolidated results for the second quarter of FY26, reporting a decline across key financial metrics compared...
Emami Transcript: Q1 25/26
Revenue was flat due to weak summer demand, but core domestic business grew 6% excluding talc. Gross margin rose to 69.4%, with PAT up 9% and pain management, BoroPlus, and digital channels driving growth. Margin outlook remains positive.
Emami Quarterly report: Q1 2026
Emami has published its Q1 2026 quarterly earnings report on July 31, 2025.
Emami Slides: Q1 2026
Emami has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on July 31, 2025.
Emami Q1 Results: Revenue flat at Rs 905 crore, Net Profit up 9% YoY
Emami Ltd. reported its financial results for the quarter ended June 30, 2025 (Q1 FY26), with modest top-line growth and steady profit expansion despite a challenging cost environment. Key Highlights ...
Nuvama on Emami share price: Buy retained, target cut to Rs 895 on FY26/27 EPS forecasts
Nuvama has maintained its buy rating on Emami Ltd, while revising its target price downward to ₹895 from ₹925. This implies a potential upside of approximately 41% from the current market price of ₹63...
Emami net profit rises 9% to Rs 162cr in Q4 FY25
Kolkata: FMCG major Emami Ltd registered a 9% jump in consolidated net profit to Rs 162 crore in Q4 of 2024-25 from Rs 146 crore in the year-ago perio.